21 patients treated with GRA for FNF in a German university hospital were retrospectively reviewed (2015-2019). After matching for age and comorbidities, a control group of 42 HA patients was established. Patient survival was determined by a Kaplan-Meier analysis. The mean follow-up (FU) was 1.5 (0-4.4) years. Function at FU was documented using the modified Harris Hip Score (mHHS) and the National Hip Fracture Database (NHFD) mobility score.
The 1-month-mortality was 19% in the GRA group and 12% in the HA group; the 1-year mortality was 71% and 49%, respectively (P = 0.01). The mHHS at FU was lower in the GRA group than in the HA group (22 [range 0-50] vs. 46 [11-80]). 82% of patients in the GRA group were bedridden post-surgery as opposed to 19% in the HA group.
Patients with HA after FNF had higher survival and better functional outcomes when compared with GRA in matched patient groups. Considering this, GRA for FNF should be selected restrictively.
方法:回顾性分析了德国大学医院接受GRA治疗FNF的21例患者(2015-2019年)。在匹配了年龄和合并症之后,建立了42例HA患者的对照组。通过Kaplan-Meier分析确定患者的存活率。平均随访时间(FU)为1.5(0-4.4)年。使用改良的Harris髋关节评分(mHHS)和国家髋部骨折数据库(NHFD)移动性评分记录FU的功能。
结果:GRA组的1个月死亡率为19%,HA组为12%;1年死亡率为71%和49%,分别为(P=0.01)。GRA组FU的mHHS低于HA组(22[范围0-50]vs.46[11-80]).GRA组82%的患者在手术后卧床不起,而HA组为19%。
结论:在匹配的患者组中,与GRA相比,FNF术后的HA患者具有更高的生存率和更好的功能结局。考虑到这一点,应当限制性地选择FNF的GRA。